Radiology Registry on Pancreatic Malignancies (RadonPams)

  • STATUS
    Recruiting
  • End date
    Mar 30, 2030
  • participants needed
    1300
  • sponsor
    IRCCS San Raffaele
Send
Updated on 24 November 2025
See if I qualify

Summary

The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.

Description

Single center, observational (retrospective and prospective) will collect all available parameters to assess the clinical outcome of the patients (progression free survival (PFS), overall survival (OS), local progression free survival LTPFS), response to treatment) with pancreatic neoplasms presenting to San Raffaele. Patient assignment to a given diagnostic and/or therapeutic procedure is not related to random assignment methods but is part of the ordinary therapeutic strategy planned for each patient on an individual basis and after multidisciplinary discussion.

Details
Condition Pancreatic Cancer, Pancreas Neoplasm, Pancreas Disease, Pancreas Cyst
Age 18years or above
Clinical Study IdentifierNCT05714111
SponsorIRCCS San Raffaele
Last Modified on24 November 2025

Eligibility

 Yes No Not Sure

Inclusion Criteria

≥18 years of age
Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage
able and willing to sign informed consent

Exclusion Criteria

Patients with non-primary pancreatic disease
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.